Regression of left ventricular hypertrophy after tafamidis therapy in a patient with transthyretin amyloidosis variant
Shusuke Yagi(Tokushima University), Masataka Sata(Tokushima University), Munkhtsetseg Tserensonom(Tokushima University), Takayuki Ise(Tokushima University Hospital), Muneyuki Kadota, Yusuke Osaki(Tokushima University), Yutaka Kawabata(Osaka University of Pharmaceutical Sciences), Daiju Fukuda(Osaka Metropolitan University), Takeshi Soeki(Tokushima University), Koji Yamaguchi(University of Occupational and Environmental Health Japan), Hirotsugu Yamada(Tokushima University Hospital), Yoshihito Saijo(Tokushima University Hospital), Tomoya Hara(Tokushima University Hospital), Rie Ueno(Tokushima University), Hiromu Yamazaki(Tokushima University), Tomomi Matsuura(Keio University), Tetsuzo Wakatsuki(Tokushima University), Kenya Kusunose(University of the Ryukyus)
Cited by 2
Related Papers
Distinct Metabolic Flow Enables Large-Scale Purification of Mouse and Human Pluripotent Stem Cell-Derived Cardiomyocytes
|Cell stem cell|2012|1.1k
Accuracy of Cuff-Measured Blood Pressure
|Journal of the American College of Cardiology|2017|271
Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells
|Cell Metabolism|2016|252
Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway
|Nature Communications|2014|250
Periadventitial Adipose Tissue Plays a Critical Role in Vascular Remodeling
|Circulation Research|2009|211